Toh bhaiyon aur behenon, ye jo 9% ka zabardast surge dikh raha hai na Tata Chemicals ke share mein, ye hui hai ekdum high volume ke saath. Stock ne aaj, April 28, 2026 ko, ₹788 ka intraday high banaya. NSE par 5.2 million se zyada shares trade hue, jo pichle din ke 0.8 million ke muqable mein bahut zyada hai. Ye rally stock ko 100-day EMA (lagbhag ₹755) ke upar le gayi aur 200-day EMA ko test karwaya. Ye do din se chal rahi 12% se zyada ki tezi ka hissa hai, jismein Nifty 50 bhi piche chhoot gaya. Ye high volume dikhata hai ki short-term mein logon ka interest bada hai, shayad results ke karan.
Lekin asli picture thodi alag hai. Chemical industry khud hi kaafi challenges face kar rahi hai jaise ki global demand ka kam hona, overcapacity, supply chain issues aur competition. In sabke karan 2021 se 2024 tak earnings mein kami aayi hai. Recovery shayad late 2025 ya early 2026 tak ho sakti hai. Is beech, Tata Chemicals pichhadta dikh raha hai. Pichhle ek saal mein, iska stock 7% gira hai jabki Nifty 50 sirf 1.3% gira tha. Pichhle do saal mein returns -30% aur teen saal mein -18% rahe, Nifty ke positive returns ke muqable mein. Haal hi mein Q3 FY26 mein company ko ₹93 crore ka net loss hua, jo pichhle saal ke ₹53 crore loss se zyada hai. Revenue bhi 1.11% kam hokar ₹3,550 crore rah gaya. Return on Equity (ROE) bhi sirf 0.80% se 2.81% ke beech hai. Analysts bhi kaafi cautious hain, jismein 'Underperform' rating aur price targets ₹726.62 se ₹738.61 ke aas paas hain. Kuch log toh 'Sell' rating bhi de rahe hain. Company ki market cap lagbhag ₹18,400 crore se ₹18,800 crore hai.
Is stock ke rise ke bawajood, company financial pressure mein hai. Earnings consistent nahi hain, jiski wajah se Q3 FY26 mein loss hua. Iska P/E ratio bhi negative earnings ke karan reliable nahi hai. Net debt bhi badhkar ₹5,596 crore (December 2025) ho gaya hai, jo pehle ₹4,884 crore (March 2025) tha. Matlab ki company par karz ka bojh badh raha hai. Kam ROE aur analysts ki 'Underperform' ya 'Sell' rating ko dekhte hue, long-term prospects par sawal uth rahe hain. SRF Ltd aur Deepak Nitrite jaise competitors zyada strong financial metrics dikha rahe hain. Aur haan, ek pattern bhi raha hai ki earnings ke baad stock price girta hai.
Ab sabki nazar May 4, 2026 ko hone wali board meeting par hai. Yahan Q4 FY26 ke audited results aur poore saal ka hisaab-kitaab aayega. Dividend ka proposal bhi discuss ho sakta hai. Investors yahan se performance aur future guidance ko judge karenge. Agar ye rally ek real turnaround ka signal hai ya sirf ek temporary technical bounce, ye results ke baad hi pata chalega.
